A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm^2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA)
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Alzheimer's Disease
Related studies linked through entity extraction aliases.
Seroquel- Agitation Associated With Dementia
- Status
- COMPLETED
- Phase
- PHASE3
Safety Study of CTS21166 to Treat Alzheimer Disease
- Status
- COMPLETED
- Phase
- PHASE1
Effects of Delivery Mode of Cognition Intervention in Early Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE1
AAB-001 (Bapineuzumab) Open-Label, Long-Term Extension Study in Patients With Mild to Moderate Alzheimer's Disease
- Status
- TERMINATED
- Phase
- PHASE2
Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's Disease
- Status
- UNKNOWN
- Phase
- PHASE2
Effect on Cognitive Performance and Safety/Tolerability of SSR180711C in Mild Alzheimer's Disease
- Status
- TERMINATED
- Phase
- PHASE2
Lutein and Alzheimer's Disease Study
- Status
- TERMINATED
- Phase
- PHASE2
Effect of LY450139 on the Long Term Progression of Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE3
The Impact of Lorazepam on Cognition in APOE e4 Carriers
- Status
- COMPLETED
- Phase
- NA
Wisconsin Brain Donor Program
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Evaluation of the COGNISION(TM) System as an Event-related Potential (ERP) Collection System.
- Status
- COMPLETED
- Phase
- N/A
Memory and Insulin in Early Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety Study of Nicotinamide to Treat Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)
- Status
- COMPLETED
- Phase
- PHASE3
Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)
- Status
- COMPLETED
- Phase
- PHASE3
Risk Evaluation and Education for Alzheimer's Disease
- Status
- COMPLETED
- Phase
- NA
Open-Label Extension Study of 23 mg Donepezil SR in Participants With Moderate to Severe Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE3
A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2